Insider Transactions in Q4 2021 at Centessa Pharmaceuticals PLC (CNTA)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 02
2021
|
Francesco De Rubertis Director |
BUY
Open market or private purchase
|
Indirect |
34,326
+0.84%
|
$411,912
$12.82 P/Share
|
|
Dec 02
2021
|
Medicxi Ventures Management (Jersey) LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
34,326
+0.84%
|
$411,912
$12.82 P/Share
|
|
Dec 01
2021
|
Francesco De Rubertis Director |
BUY
Open market or private purchase
|
Indirect |
60,304
+1.49%
|
$723,648
$12.62 P/Share
|
|
Dec 01
2021
|
Medicxi Ventures Management (Jersey) LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
60,304
+1.49%
|
$723,648
$12.62 P/Share
|
|
Nov 30
2021
|
Francesco De Rubertis Director |
BUY
Open market or private purchase
|
Indirect |
36,847
+0.93%
|
$405,317
$11.62 P/Share
|
|
Nov 30
2021
|
Medicxi Ventures Management (Jersey) LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
36,847
+0.93%
|
$405,317
$11.62 P/Share
|
|
Nov 29
2021
|
Francesco De Rubertis Director |
BUY
Open market or private purchase
|
Indirect |
56,706
+1.43%
|
$623,766
$11.7 P/Share
|
|
Nov 29
2021
|
Medicxi Ventures Management (Jersey) LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
56,706
+1.43%
|
$623,766
$11.7 P/Share
|
|
Nov 26
2021
|
Francesco De Rubertis Director |
BUY
Open market or private purchase
|
Indirect |
11,817
+0.31%
|
$129,987
$11.34 P/Share
|
|
Nov 26
2021
|
Medicxi Ventures Management (Jersey) LTD > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
11,817
+0.31%
|
$129,987
$11.34 P/Share
|
|
Nov 18
2021
|
Aaron Kantoff Director |
BUY
Open market or private purchase
|
Direct |
10,000
+14.29%
|
$110,000
$11.98 P/Share
|
|
Nov 16
2021
|
Tia L Bush Chief Technology & Quality Ofc |
BUY
Open market or private purchase
|
Indirect |
5,000
+26.65%
|
$60,000
$12.33 P/Share
|
|
Nov 16
2021
|
Saurabh Saha Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect |
23,000
+50.0%
|
$276,000
$12.28 P/Share
|